Serum alpha2-Heremans-Schmid glycoprotein levels in subjects with simple overweight and obesity
10.3760/cma.j.issn.1000-6699.2016.01.011
- VernacularTitle:单纯性超重和肥胖人群血清胎球蛋白 A水平的变化
- Author:
Zhongwei ZHOU
;
Huixiang JU
;
Mingzhong SUN
;
Fuwan DING
;
Dongmei JIANG
;
Yuqiao JI
;
Jianwei JI
- Publication Type:Journal Article
- Keywords:
Overweight;
Obesity;
alpha2-Heremans-Schmid glycoprotein
- From:
Chinese Journal of Endocrinology and Metabolism
2016;(1):42-46
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate serum alpha2-Heremans-Schmid glycoprotein ( AHSG ) level and its relationship with associated clinical parameters in subjects with simple overweight and obesity. Methods Forty-nine subjects with obesity ( OB group) , 176 subjects with overweight ( OW group) , and 327 individuals with normal weight ( NW group) were randomly enrolled. The clinical data were collected and serum levels of AHSG and adiponectin ( APN) were determined by ELISA. The associations of serum AHSG level with other clinical parameters were assessed by Pearson correlation analysis and multiple linear regressive model. Results Serum AHSG levels were higher in OW and OB groups than that in NW group[(276. 30 and 302. 10 vs 241. 60)μg/ml], being especially higher in OB group (P<0. 05 or P<0. 01). Serum AHSG level in NW group was positively associated with fasting plasma glucose, homoeostasis model assessment of insulin resistance index, C-reactive protein (CRP), triglycerides, and free fatty acids ( FFA ) , but negatively associated with age and APN. In OW and OB groups, AHSG was also positively associated with body mass index, waist hip ratio(WHR), and low density lipoprotein cholesterol(P<0. 05 or P<0. 01) except the aforementioned clinical parameters. In multiple linear regression model, AHSG was positively associated with WHR, CRP, and FFA, and was negatively associated with APN ( P<0. 05 or P<0. 01). Conclusion The raised AHSG level in overweight and obese subjects may be a risk factor for obesity-related diseases.
